期刊文献+

宫颈癌根治术后三维适形放疗与调强放疗治疗效果比较 被引量:16

Effect of three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy after radical hysterectomy for cervical cancer
原文传递
导出
摘要 目的比较宫颈癌根治术后患者行盆腔三维适形放疗(3-dimensional conformal radiotherapy,3DCRT)与调强放疗(intensity modulated radiotherapy,IMRT)的效果与安全性。方法宫颈癌根治术后行放疗患者105例,采用倾向配比评分法进行配对分析后选取56例患者,其中28例行3DCRT(3DCRT组),28例行IMRT(IMRT组),随访观察2组3a生存率、3a复发转移率,记录不良反应发生情况。结果 3DCRT组3a生存率(83.4%)、3a复发转移率(23.5%)与IMRT组(86.5%、17.8%)比较差异均无统计学意义(P>0.05);3DCRT组消化系统、泌尿系统急性不良发应发生率及消化系统慢性不良反应发生率均高于IMRT组(P<0.05),急性血液学及慢性泌尿系统不良反应发生率与IMRT组比较差异无统计学意义(P>0.05)。结论宫颈癌根治术后行3DCRT与IMRT均具有较好疗效,但应用IMRT可减轻不良反应。 Objective To compare the effect and safety of pelvic three-dimensional conformal radiotherapy (3DCRT) and intensity-modulated radiotherapy (IMRT) after radical hysterectomy in patients with cervical cancer. Methods In 105 patients receiving radiotherapy for cervical cancer after radical hysterectomy, 56 patients were selected by propensity score matching, in which 28 patients underwent 3DCRT (3DCRT group) and 28 patients underwent IMRT (IMRT group). The 3-year survival rate, 3-year relapse and metastasis rate, and the adverse reactions were observed and recorded in two groups. Results There were no significant differences in the 3-year survival rate and 3-year relapse and metastasis rate between 3DCRT group (83.4%, 23.5%) and IMRT group (86.5%, 17.8%) (P〈0. 05). The incidences of the acute adverse reactions of digestive system and urinary system and chronic adverse reactions of digestive system were significantly higher in 3DCRT group than those in IMRT group (P〈0.05), and there were no significant differences in the incidences of acute hematologic toxicity and chronic adverse reaction of urinary system between two groups (P〈 0.05). Conclusion Both 3DCRT and IMRT are effective for cervical cancer after radical hysterectomy, and IMRT can alleviate the adverse reactions.
出处 《中华实用诊断与治疗杂志》 2018年第1期84-86,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 河南省科技攻关计划项目(142102310411)
关键词 宫颈癌 三维适形放疗 调强放疗 总生存期 不良反应 Cervical cancer three-dimensional conformal radiotherapy intensity modulated radiotherapy overall survival adverse reaction
  • 相关文献

参考文献6

二级参考文献42

  • 1宫颈癌及癌前病变规范化诊疗指南(试行)[J].中国医学前沿杂志(电子版),2013,5(8):40-49. 被引量:252
  • 2浦红,何成章,王震吾,毛玉荣,张振宇,金建荣,范强.三维适形调强放疗在复发性妇科恶性肿瘤中的应用[J].中国现代医药杂志,2007,9(10):37-38. 被引量:2
  • 3Zhai DY, Yin Y, Gong GZ, et al. RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: A treatment planning comparison with fixed field IMRT. Journal of Radiation Research : Official Organ of the Japan. Radiation Research Society,2013,54 : 166-173. 被引量:1
  • 4Albuquerque K, Giangreco D, Morrison C, et al. Radiation-related pre- dictors of hematologic toxicity after concurrent chemoradiation for cervi- cal cancer and implications for bone marrow-sparing pelvic IMRT. Inter- national Journal of Radiation Oncology, Biology, Physics, 2011,79 : 1043 -1047. 被引量:1
  • 5Shih KK, Folkert MR, Kollmeier MA, et al. Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postopera- tive pelvic radiation. Gynecologic Oncology: An International Journal, 2013,128:540-543. 被引量:1
  • 6Folkert MR, Shih KK, Abu-Rustum NR, et al. Postoperative pelvic inten- sity-modulated radiotherapy and concurrent chemotherapy in intermedi- ate- and high-risk cervical cancer. Gynecologic Oncology: An Interna- tional Journal ,2013,128:288-293. 被引量:1
  • 7Takeku,na M, Kuji S, Tanaka A, et al. Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer[ J ]. J Gynecol Oneol,2015,26 (3) :185-192. 被引量:1
  • 8Pathy S, Kumar L, Pandey RM, et al. Impact of treatment time on chemoradiotherapy in locally advanced cervical car- cinoma[J]. Asian Pac J Cancer Prey ,2015,16(12) :5075- 5079. 被引量:1
  • 9Kaidar-Person O, Yosefia S, Abdah-Bortnyak R. Response of adenocarcinoma of the uterine cervix to chemoradiothera- py[J]. Oncol Lett,2015,9(6) :2791-2794. 被引量:1
  • 10Jelavie TB, Mise BP, Strikic A, et al. Adjuvant chemothera- py in locally advanced cervical cancer after treatment with concomitant chemoradiotherapy-room for improvement[ J]. Anticancer Res ,2015,35 ( 7 ) :4161-4165. 被引量:1

共引文献44

同被引文献114

引证文献16

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部